NJ CAC Resource: Research


New Jersey Addictions: Charts and Graphs

Charts, Graphs and Data title pagePart One: US Information

Part Two: NJ Information

New Jersey is in the midst of a opiate/heroin crisis. The crisis has vast implications for families of loved ones with psychiatric disabilities. More information for the public is desperately needed to understand the gravity of the crisis.

As part of work for the New Jersey Behavioral Health Planning Council, PyschOdyssey is assembling publicly available  charts, graphs and data that describe this urgent problem. Information has been sourced about the crisis at both the national and state level.


Kleber, H. D. (2007). Pharmacologic treatments for opioid dependence: detoxification and maintenance options. Dialogues in Clinical Neuroscience, 9(4), 455-470.

Abstract: While opioid dependence has more treatment agents available than other abused drugs, none are curative. They can, however, markedly diminish withdrawal symptoms and craving, and block opioid effects due to lapses. The most effective withdrawal method is substituting and tapering methadone or buprenorphine. -2 Adrenergic agents can ameliorate untreated symptoms or substitute for agonists if not available. Shortening withdrawal by precipitating it with narcotic antagonists has been studied, but the methods are plagued by safety issues or persisting symptoms. Neither the withdrawal agents nor the methods are associated with better long-term outcome, which appears mostly related to post-detoxification treatment. Excluding those with short-term habits, the best outcome occurs with long-term maintenance on methadone or buprenorphine accompanied by appropriate psychosocial interventions. Those with strong external motivation may do well on the antagonist naltrexone. Currently, optimum duration of maintenance on either is unclear. Better agents are needed to impact the brain changes related to addiction.

Stirling, S. (2016). Welcome to Herointown, New Jersey’s 4th-largest city. NJ.com.

Navigate with others
  • Print
  • Facebook
  • Twitter
  • Google Bookmarks
  • Add to favorites
  • LinkedIn
  • RSS
  • Digg
  • Yahoo! Buzz